FHIR IG analyticsBy Version
By Authority
By Realm
Start Prev Rows 56600 - 56800 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) | Usage # |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-topographymetastases.json | NKRS - Topography of Metastases | active | 2022-02 | ch | hl7 | internal | 2 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-lymphaticinvasion.json | NKRS - Lymphatic Invasion | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-venousinvasion.json | NKRS - Venous Invasion | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-sentinellymphnodeassessment.json | NKRS - Sentinel Lymph Node Assessment | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-luganostaging.json | NKRS - Lugano Staging | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-diagnosticmethodsused.json | NKRS - Diagnostic Methods Used | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-cn.json | NKRS - cN | active | 2022-02 | ch | hl7 | internal | 1 | ||
| lt.hl7.fhir.lab | R5 | ValueSet-her2-receptor-status.json | Her2 Receptor Statuses | active | 2026-03 | 1 | |||||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-her2receptorstatus.json | NKRS - Her2 Receptor Status | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-issstaging.json | NKRS - ISS Staging | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-stjudemurphystaging.json | NKRS - St. Jude / Murphy Staging | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-serumtumourmarkers.json | NKRS - Serum Tumour Markers | active | 2022-02 | ch | hl7 | internal sct | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-tnmstagegroup.json | NKRS - TNM Stage Group | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-pn.json | NKRS - pN | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-cm.json | NKRS - cM | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-pm.json | NKRS - pM | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-hcg.json | NKRS - β-hCG | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-ldh.json | NKRS - LDH | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-methodfirstdetection.json | NKRS - Method of First Detection | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-diabetesmellitus.json | NKRS - Diabetes Mellitus | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-liverdisease.json | NKRS - Liver Disease | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-alphafetoprotein.json | NKRS - α-fetoprotein | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-typerecurrencetransformation.json | NKRS - Type of Recurrence/Transformation | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-msuffixofpt.json | NKRS - m-Suffix of pT | active | 2022-02 | ch | hl7 | internal | |||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-ct.json | NKRS - cT | active | 2022-02 | ch | hl7 | internal | 1 | ||
| signal.core.r4 | R4 | valueset-days-of-week.json | DaysOfWeek | normative | 5 | fhir | 2019-10 | us | hl7 | fhir | |
| hl7.fhir.uv.extensions | R5 | ValueSet-concept-map-equivalence.json | Concept Map Equivalence Value Set | trial-use | 3 | fhir | 2023-01 | uv | hl7 | fhir | |
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.1043.json | Specimen Quality (HL7) | active | 2008-01 | us | tho | ||||
| kl.dk.fhir.gateway | R4 | ValueSet-DeliveryTypes.json | DeliveryTypes | active | 2024-10 | dk | 1 | ||||
| kl.dk.fhir.prevention | R4 | ValueSet-DeliveryTypes119.json | DeliveryTypes | active | 2024-06 | dk | 1 | ||||
| kl.dk.fhir.rehab | R4 | ValueSet-DeliveryTypes140.json | DeliveryTypes | active | 2024-10 | dk | 1 | ||||
| hl7.terminology | R5 | ValueSet-v3-EntityDeterminerDetermined.json | EntityDeterminerDetermined | active | 2014-03 | uv | hl7 | tho | 3 | ||
| hl7.terminology | R5 | ValueSet-v3-EntityDeterminerDescribedQuantified.json | EntityDeterminerDescribedQuantified | retired | 2012-03 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v3-ParticipationDestination.json | ParticipationDestination | active | 2014-03 | uv | hl7 | tho | |||
| careconnect.stu3.03.00.00 | R3 | ValueSet-CareConnect-DischargeDestination-1.json | NHS Data Model and Dictionary Discharge Destination | draft | 2018-11 | hl7 | 4 | ||||
| hl7.terminology | R5 | ValueSet-v3-ActInvoiceDetailGenericCode.json | ActInvoiceDetailGenericCode | active | 2014-03 | uv | hl7 | tho | 2 | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.3591.json | Source of Payment Typology (PHDSC) | active | 2021-01 | us | |||||
| niceprofiling.v23q1 | R3 | NICE_LaboratoryTestResultCodelist.json | NICE Laboratory Test Results | active | loinc | ||||||
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet-pqcmc-representation-types.json | Representation Types | trial-use | 2 | brr | 2025-07 | us | hl7 | ncit | 4 |
| hl7.fhir.uv.cpg | R4 | ValueSet-cpg-recommendation-direction-vs.json | CPG Recommendation Direction Value Set | active | cds | 2024-11 | uv | hl7 | fhir | 1 | |
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.915.json | Discharge Disposition (HL7) | active | 2021-01 | us | tho | ||||
| ca.on.oh.setp.iar.dev | R4 | ValueSet-ProvincialDocumentTypeEHR.json | Provincial Document Kind EHR | active | 2025-10 | ca | hl7 | loinc | |||
| ca.on.ehr.r4 | R4 | ValueSet-document-kind.json | Document Kind EHR | active | 2026-02 | ca | national | 2 | |||
| ca.on.ehr.r4 | R4 | ValueSet-document-role.json | Document Role EHR | active | 2026-02 | ca | national | 2 | |||
| ca.on.ehr.r4 | R4 | ValueSet-document-setting.json | Document Setting EHR | active | 2026-02 | ca | national | 2 | |||
| ca.on.ehr.r4 | R4 | ValueSet-document-subject-matter-domain.json | Document Subject Matter Domain EHR | active | 2026-02 | ca | national | 2 | |||
| ca.on.ehr.r4 | R4 | ValueSet-document-type-of-service.json | Document Type Of Service EHR | active | 2025-11 | ca | national | 2 | |||
| ca.on.accdr.r4 | R4 | vs-KOD.json | Document KOD | retired | 2023-05 | loinc | 2 | ||||
| ca.on.accdr.r4 | R4 | vs-role.json | Document Role | retired | 2023-05 | ca | national | loinc | 2 | ||
| ca.on.accdr.r4 | R4 | vs-Setting.json | Document Setting | retired | 2023-05 | loinc | 2 | ||||
| ca.on.accdr.r4 | R4 | vs-SMD.json | Document SMD | retired | 2023-05 | loinc | 2 | ||||
| ca.on.accdr.r4 | R4 | vs-tos.json | Document TOS | retired | 2023-05 | ca | national | loinc | 2 | ||
| hl7.fhir.uv.cg-incubator | R6 | ValueSet-moleculardefinition-representation-focus.json | Molecular Definition Representation Focus VS | informative | 1 | cg | 2025-01 | uv | hl7 | fhir | 1 |
| hl7.terminology | R5 | ValueSet-v3-MaritalStatus.json | MaritalStatus | active | 2014-03 | uv | hl7 | tho | 3 | ||
| hl7.fhir.uv.emedicinal-product-info | R5 | ValueSet-doseForm.json | Dose Form | trial-use | brr | 2026-04 | uv | hl7 | fhir | ||
| hl7.fhir.us.davinci-drug-formulary | R4 | ValueSet-DrugTierVS.json | Drug tier of medication in health plan | trial-use | phx | 2025-02 | us | hl7 | fhir | 3 | |
| hl7.fhir.uv.genomics-reporting | R4 | ValueSet-functional-effect-vs.json | Functional Effect Value Set | trial-use | 2 | cg | 2026-01 | uv | hl7 | 1 | |
| hl7.fhir.uv.cg-incubator | R6 | ValueSet-moleculardefinition-literal-encoding.json | Molecular Definition Literal Encoding VS | informative | 1 | cg | 2025-01 | uv | hl7 | fhir | 1 |
| bloodpressure | R4 | ValueSet-MeasurementSetting.json | Measurement Setting value set | active | 2024-04 | sct | 2 | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7153.json | Estimated Time of Death No Labor Ongoing (NCHS) | active | 2014-01 | us | sct | ||||
| hl7.fhir.fr.core | R4 | ValueSet-fr-core-vs-practitioner-role-exercice.json | FR Core ValueSet PractitionerRole Exercice | active | 2026-03 | fr | hl7 | 1 | |||
| hl7.fhir.uv.testing | R6 | ValueSet-testscript-scope-conformance-codes.json | Test Script Scope Conformance Type Value Set | draft | 4 | fhir | 2021-01 | uv | hl7 | fhir | |
| hl7.terminology | R5 | ValueSet-v3-TransferActReason.json | TransferActReason | active | 2014-03 | uv | hl7 | tho | |||
| hl7.fhir.be.medication | R4 | ValueSet-BeMedicationExposureIntentVS.json | Medication exposure intent | active | 2026-03 | be | hl7 | sct | 2 | ||
| hl7.fhir.be.terminology | R4 | ValueSet-BeMedicationExposureIntentVS.json | Medication exposure intent | active | 2025-10 | be | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1221.176.json | Methotrexate Injection | active | 2024-04 | us | hl7 | rx | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1221.169.json | Abortion, Spontaneous / Miscarriage | active | 2024-04 | us | hl7 | icd | 2 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1221.171.json | Abortion, Spontaneous / Miscarriage | active | 2024-04 | us | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1221.170.json | Abortion, Spontaneous / Miscarriage | active | 2024-04 | us | hl7 | sct | 2 | ||
| hl7.terminology | R5 | ValueSet-v3-ParticipationTargetLocation.json | ParticipationTargetLocation | active | 2014-03 | uv | hl7 | tho | 2 | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7361.json | Disposition OPD (NCHS) | active | 2015-01 | us | sct tho oid | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7437.json | Disposition ED (NCHS) | active | 2015-01 | us | sct tho oid | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7360.json | Discharge Disposition IP (NCHS) | active | 2014-12 | us | tho | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7362.json | Follow-up Attempt Outcome (NCHS) | active | 2015-01 | us | sct tho oid | ||||
| ca.on.mi.r4 | R4 | ValueSet-mi-document-type.json | Medical Imaging Document Type | active | 2024-04 | ca | loinc | 1 | |||
| dk.ehealth.sundhed.fhir.ig.core | R4 | ValueSet-ehealth-usage-context-type.json | eHealth Usage Context Type | active | 2020-11 | dk | tho | 1 | |||
| ca.on.ehr.r4 | R4 | ValueSet-PrescriptionDrugForm.json | Prescription Drug Form | active | 1900-01 | ca | national | sct tho | 7 | ||
| ca.on.ehr.r4 | R4 | ValueSet-PharmaceuticalDoseFormCode.json | PharmaceuticalDoseFormCode | active | 1900-01 | ca | national | sct | 5 | ||
| hl7.terminology | R5 | ValueSet-citation-summary-style.json | Citation Summary Style | trial-use | 1 | cds | 2025-01 | uv | hl7 | tho | 1 |
| fhir.argonaut.scheduling | R3 | ValueSet-argo-slot-status.json | Argonaut Slot Status Codes | active | 2018-03 | us | hl7 | fhir | 1 | ||
| hl7.fhir.uv.admin-incubator | R6 | ValueSet-verificationresult-need.json | need | trial-use | 3 | pa | 2018-06 | uv | hl7 | tho | |
| hl7.terminology | R5 | ValueSet-verificationresult-need.json | Need | active | pa | 2024-04 | uv | hl7 | tho | ||
| dk.ehealth.sundhed.fhir.ig.core | R4 | ValueSet-participant-function.json | Participant Function | active | 2024-09 | dk | 2 | ||||
| dk.ehealth.sundhed.fhir.ig.core | R4 | ValueSet-material-assignment-participant-function.json | Material Assignment Participant Function | active | 2025-07 | dk | fhir | 1 | |||
| dk.ehealth.sundhed.fhir.ig.core | R4 | ValueSet-material-registration-participant-function.json | Material Registration Participant Function | active | 2025-07 | dk | fhir | 1 | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.113883.3.5.20.2.json | USDA Subject Function | active | 2010-01 | us | oid | ||||
| ca.on.oh.mha-pds | R4 | FunctionalCentreCode-vs.json | Functional Centre Code | active | 2022-08 | 1 | |||||
| nhsdigital.fhir.stu3 | R3 | ValueSet-NHSDataDictionary-PersonStatedGender-1.json | NHS Data Model and Dictionary Person Stated Gender Code | active | 2017-08 | hl7 | 1 | ||||
| careconnect.stu3.03.00.00 | R3 | ValueSet-CareConnect-NHSDataDictionary-PersonStatedGender-1.json | NHS Data Model and Dictionary Person Stated Gender Code | active | 2017-08 | hl7 | 1 | ||||
| nhsdigital.fhir.stu3 | R3 | ValueSet-CareConnect-AdministrativeGender-1.json | Administrative Gender | active | 5 | pc | 2017-04 | hl7 | fhir | 3 | |
| careconnect.stu3.03.00.00 | R3 | ValueSet-CareConnect-AdministrativeGender-1.json | Administrative Gender | draft | 5 | pc | 2017-04 | hl7 | fhir | 13 | |
| csiro.fhir.au.smartforms | R4 | ValueSet-administrative-gender.json | AdministrativeGender | normative | 5 | pa | 2019-10 | au | hl7 | fhir | |
| hl7.fhir.us.vrdr | R4 | ValueSet-vrdr-administrative-gender-vs.json | Administrative Gender ValueSet | active | pher | 2024-10 | us | hl7 | fhir | 2 | |
| ca.on.oh-olis | R4 | vs-AdministrativeGender.json | AdministrativeGender | active | hl7 | fhir | 1 | ||||
| hl7.terminology | R5 | ValueSet-v3-AdministrativeGender.json | AdministrativeGender | active | 2014-03 | uv | hl7 | tho | 7 | ||
| ehealth4u.package | R4 | CYEHRVSEHDSIAdministrativeGender.json | Cyprus EHR Value Set: eHDSI Administrative Gender | active | tho | ||||||
| hl7.terminology | R5 | ValueSet-v3-ActRelationshipHasGeneralization.json | ActRelationshipHasGeneralization | active | 2014-03 | uv | hl7 | tho | |||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-treatmentgoal.json | NKRS - Treatment Goal | active | 2022-02 | ch | hl7 | sct | 1 | ||
| hl7.fhir.uv.extensions.r3 | R3 | ValueSet-variable-handling.json | Evidence Variable Handling | trial-use | 5 | cds | 2020-12 | uv | hl7 | fhir | |
| hl7.terminology | R5 | ValueSet-statistic-model-code.json | Statistic Model Code | trial-use | 1 | cds | 2025-01 | uv | hl7 | tho | |
| ca.on.oh.mha.pds | R4 | EducationalAttainment-vs.json | Educational Attainment | draft | 1 | ||||||
| ca.on.oh.mha-pds | R4 | vs-HighestLevelOfEducationAttained-v1.json | Highest Level of Education Attained | active | 2022-08 | ca | hl7 | sct tho | 1 | ||
| ca.on.oh.mha-pds | R4 | ValueSet.encounter-identifier-system.json | EncounterIdentifierValueSet | active | 2022-08 | ca | hl7 | 2 | |||
| ca.on.oh.mha-pds | R4 | ValueSet.patient-jhn-identifier-system.json | PatientJHNIdentifierSystem | active | 2022-08 | ca | hl7 | 2 | |||
| ca.on.oh.mha-pds | R4 | ValueSet.patient-mrn-identifier-system.json | PatientMRNIdentifierSystem | active | 2022-08 | ca | hl7 | 2 | |||
| ca.on.oh.mha-pds | R4 | ValueSet.patient-episode-of-care-identifier-system.json | EpisodeOfCareIdentifierValueSet | active | 2022-08 | ca | hl7 | 3 | |||
| ca.on.oh.mha-pds | R4 | ValueSet.ServiceRequest-identifier-system.json | ServiceRequestIdentifierValueSet | active | 2022-08 | ca | hl7 | 3 | |||
| ca.healthpei.io.core | R4 | VS_NVC_RouteOfAdmin.json | Route Of Administration | active | 2024-06 | ca | sct | 1 | |||
| hl7.fhir.us.ph-library | R4 | ValueSet-us-ph-valueset-message-significance-category.json | US Public Health ValueSet - Message Significance Category | trial-use | 1 | inm | 2019-10 | us | hl7 | fhir | |
| hl7.fhir.us.ecr.r4b | R4B | ValueSet-us-ph-message-significance-category.json | US Public Health Message Significance Category | trial-use | 1 | pher | 2019-10 | us | hl7 | fhir | |
| hl7.terminology | R5 | ValueSet-v3-FirstFillPharmacySupplyType.json | FirstFillPharmacySupplyType | active | 2014-03 | uv | hl7 | tho | |||
| ca.on.oh-dhdr | R4 | EncounterType.json | Encounter Type | active | 2019-02 | us | hl7 | ||||
| hl7.terminology | R5 | ValueSet-measure-data-usage.json | MeasureDataUsage | active | 2 | cqi | 2024-04 | uv | hl7 | tho | 3 |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.135.json | Bleeding at Critical Site | active | 2021-06 | us | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.145.json | Bleeding at Non Critical Site | active | 2025-02 | us | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.143.json | Bleeding at Critical Site | active | 2021-06 | us | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.125.json | Bleeding at Non Critical Site | active | 2025-02 | us | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.146.json | Bleeding at Non Critical Site | active | 2021-06 | us | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.144.json | Bleeding at Critical Site | active | 2021-06 | us | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1206.12.json | Opioid (Oral Tablets and Patches only) | active | 2019-12 | us | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.117.1.7.1.1.json | Major Surgical Procedure | active | 2025-02 | us | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.666.5.1250.json | Major Surgical Procedure | active | 2025-02 | us | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.11.json | Care Experience Preferences Grouping | active | 2022-03 | us | hl7 | vsac | 2 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.9.json | Treatment Intervention Preferences Grouping | active | 2024-03 | us | hl7 | vsac | 1 | ||
| hl7.terminology | R5 | ValueSet-v3-ActSubstanceAdministrationImmunizationCode.json | ActSubstanceAdministrationImmunizationCode | active | 2014-03 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v3-AdjudicatedWithAdjustments.json | AdjudicatedWithAdjustments | active | 2014-03 | uv | hl7 | tho | |||
| fhir.r4.wales.discovery | R4 | ValueSet-DataStandardsWales-JobRole.json | Data Standards Wales Job Role | retired | 2021-08 | us | hl7 | ||||
| hl7.terminology | R5 | ValueSet-dose-rate-type.json | DoseAndRateType | active | 1 | fhir | 2026-03 | uv | hl7 | tho | |
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7363.json | Specialty Unit Type (NCHS) | active | 2014-12 | us | cdc | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7364.json | Type of clinic/location (NCHS) | active | 2014-12 | us | cdc | ||||
| hl7.fhir.uv.extensions.r4b | R4B | ValueSet-device-specification-category.json | Device Specification Category | trial-use | 2 | oo | 2022-03 | uv | hl7 | fhir | |
| hl7.terminology | R5 | ValueSet-v3-VaccineType.json | VaccineType | active | 2014-03 | uv | hl7 | tho | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7365.json | Priority (Type) of Admission or Visit (NCHS) | active | 2015-01 | us | sct tho | ||||
| hl7.fhir.uv.extensions.r3 | R3 | ValueSet-spdx-license.json | S P D X License | trial-use | 4 | fhir | 2020-12 | uv | hl7 | fhir | |
| ch.fhir.ig.ch-term | R4 | ValueSet-ch-vacd-swissmedic-immunesera-vs.json | CH VACD Swissmedic Authorized Immunsera Codes | active | 2026-03 | ch | hl7 | ||||
| ch.fhir.ig.ch-term | R4 | ValueSet-ch-vacd-swissmedic-immunoglobulin-vs.json | CH VACD Swissmedic Authorized Immunoglobulin Codes | active | 2026-03 | ch | hl7 | 2 | |||
| hl7.fhir.us.covid19library | R4 | ValueSet-state-codes-vs.json | State Codes Value Set | active | 2022-07 | us | hl7 | sct | |||
| hl7.fhir.ca.baseline | R4 | ValueSet-prescriptionmedicinalproduct.json | Prescription Medicinal Product | draft | 2026-02 | ca | hl7 | ||||
| hl7.fhir.uv.sdc | R4 | ValueSet-dex-mimetype.json | DEX mapping language mime types | informative | fhir | 2026-03 | uv | hl7 | ietf | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.3164.json | Sputum Culture Conversion Not Documented Reason | active | 2008-01 | us | sct tho oid | ||||
| ch.fhir.ig.ch-term | R4 | ValueSet-ch-vacd-vaccines-snomedct-vs.json | CH VACD Snomed CT for VaccineCode | active | 2026-03 | ch | hl7 | sct | 6 | ||
| ch.fhir.ig.ch-term | R4 | ValueSet-ch-vacd-vaccines-vs.json | CH VACD All Swiss Vaccine Codes | active | 2026-03 | ch | hl7 | sct | 5 | ||
| ch.fhir.ig.ch-term | R4 | ValueSet-ch-vacd-swissmedic-vaccines-vs.json | CH VACD Swissmedic Authorized Vaccine Codes | active | 2026-03 | ch | hl7 | 3 | |||
| ch.fhir.ig.ch-term | R4 | ValueSet-snomedct-concept-viraldiseases-vs.json | Snomed CT Concept Viral Diseases | active | 2026-03 | ch | hl7 | sct | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.3593.json | Cause of Death (ICD-10) | draft | us | icd | 1 | ||||
| signal.core.r4 | R4 | valueset-questionnaire-dacods-living-situation.json | Questionnaire DACODS Living Situation | draft | 1 | pa | us | hl7 | |||
| hl7.terminology | R5 | ValueSet-v3-ParticipationOrigin.json | ParticipationOrigin | active | 2014-03 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v3-VaccineManufacturer.json | VaccineManufacturer | active | 2014-03 | uv | hl7 | tho | |||
| hl7.fhir.us.vrdr | R4 | ValueSet-vrdr-death-certification-event-max-vs.json | Event Code for Death Certificate Composition - Max | active | pher | 2024-10 | us | hl7 | fhir sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.3157.4057.json | Emergency Department Encounter | active | 2020-07 | us | hl7 | cpt | |||
| ch.fhir.ig.ch-vacd | R4 | ValueSet-ch-vacd-risks-vs.json | Swiss Risks For Immunizations | active | 2026-03 | ch | hl7 | internal | 1 | ||
| ch.fhir.ig.ch-vacd | R4 | ValueSet-ch-vacd-risks-medical-vs.json | Swiss Medical Risks For Immunizations | active | 2026-03 | ch | hl7 | sct | 1 | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.3303.json | Specimen Source (Measles) | active | 2010-01 | us | sct tho | ||||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.3307.json | Specimen Source (Mumps) | active | 2010-01 | us | sct tho | ||||
| careconnect.stu3.03.00.00 | R3 | ValueSet-CareConnect-AdmissionMethod-1.json | NHS Data Model and Dictionary Admission Method | draft | 2018-11 | hl7 | 1 | ||||
| careconnect.stu3.03.00.00 | R3 | ValueSet-CareConnect-DischargeMethod-1.json | NHS Data Model and Dictionary Discharge Method | draft | 2018-11 | hl7 | 1 | ||||
| hl7.fhir.us.breastcancer | R3 | ValueSet-oncology-LymphNodeClinicalMethodVS.json | BC LymphNodeClinicalMethodVS ValueSet | draft | 2018-08 | us | hl7 | sct | 2 | ||
| hl7.terminology | R5 | ValueSet-v3-xActFinancialProductAcquisitionCode.json | x_ActFinancialProductAcquisitionCode | active | 2014-03 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v3-ActProductAcquisitionCode.json | ActProductAcquisitionCode | active | 2014-03 | uv | hl7 | tho | |||
| hl7.fhir.uv.cg-incubator | R6 | ValueSet-genomicstudy-methodtype.json | Genomic Study Method Type VS | draft | 1 | cg | 2022-08 | uv | hl7 | fhir | 1 |
| hl7.terminology | R5 | ValueSet-characteristic-method.json | CharacteristicMethod | active | 1 | cds | 2026-03 | uv | hl7 | tho | |
| hl7.fhir.us.breastcancer | R3 | ValueSet-oncology-BreastCancerDetectionVS.json | BC BreastCancerDetectionVS ValueSet | draft | 2018-08 | us | hl7 | sct | 4 | ||
| signal.core.r4 | R4 | valueset-service-referral-method.json | ReferralMethod | draft | 1 | pa | 2019-10 | us | hl7 | tho | |
| hl7.terminology | R5 | ValueSet-service-referral-method.json | ReferralMethod | active | 1 | pa | 2024-04 | uv | hl7 | tho | |
| hl7.fhir.uv.extensions | R5 | ValueSet-major-fhir-version.json | Major FHIR Versions | trial-use | 3 | fhir | 2026-04 | uv | hl7 | fhir | |
| hl7-france-fhir.administrative-2022 | R4 | fr-practitioner-specialty-R4.json | fr-practitioner-specialty | active | 5 | pc | 2019-12 | hl7 | 8 | ||
| hl7.fhir.fr.core | R4 | ValueSet-fr-core-vs-practitioner-specialty.json | FR Core ValueSet Practitioner specialty | informative | 5 | pc | 2026-03 | fr | hl7 | 6 | |
| hl7.fhir.us.davinci-pas | R4 | ValueSet-PASInformationChangeMode.json | PAS Information Change Mode Value Set | trial-use | 4 | fm | 2026-03 | us | hl7 | fhir | 1 |
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7277.json | Transport Mode to Hospital (NCHS) | active | 2015-01 | us | sct | ||||
| hl7.terminology | R5 | ValueSet-v3-RoleClassActiveMoiety.json | RoleClassActiveMoiety | active | 2014-03 | uv | hl7 | tho | |||
| hl7.fhir.us.breastcancer | R3 | ValueSet-oncology-MorphologyBehaviorVS.json | BC MorphologyBehaviorVS ValueSet | draft | 2018-08 | us | hl7 | sct | 2 | ||
| ca.on.oh-olis | R4 | ValueSet-patient-contactrelationship.json | Patient Contact Relationship | normative | 5 | pa | 2019-10 | hl7 | tho | ||
| hl7.fhir.uv.cg-incubator | R6 | ValueSet-coordinatesystem-normalizationmethod.json | Coordinate System Normalization Method ValueSet | informative | 0 | cg | 2026-03 | uv | hl7 | fhir | 1 |
| hl7.fhir.us.breastcancer | R3 | ValueSet-oncology-DCISNuclearGradeVS.json | BC DCISNuclearGradeVS ValueSet | draft | 2018-08 | us | hl7 | sct | 2 | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.914.json | Diagnosis Priority (HL7) | active | 2008-01 | us | tho | ||||
| hl7.terminology | R5 | ValueSet-v3-BuildingNumber.json | BuildingNumber | active | 2014-03 | uv | hl7 | tho | |||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.7830.json | Observation Identifier V2 (IIS) | active | 2018-01 | us | loinc | ||||
| hl7.terminology | R5 | ValueSet-v3-ObservationInterpretationOustsideThreshold.json | ObservationInterpretationOustsideThreshold | active | 2014-03 | uv | hl7 | tho | 1 | ||
| hl7.terminology | R5 | ValueSet-v3-ObservationInterpretationProtocolInclusion.json | ObservationInterpretationProtocolInclusion | active | 2014-03 | uv | hl7 | tho | |||
| ch.fhir.ig.ch-vacd | R4 | ValueSet-ch-vacd-risks-occupation-vs.json | Swiss Occupation Risks For Immunizations | active | 2026-03 | ch | hl7 | internal sct | 1 | ||
| hl7.fhir.uv.extensions.r4b | R4B | ValueSet-device-operation-mode.json | FHIR Device Operation Mode | trial-use | 2 | oo | 2022-03 | uv | hl7 | fhir | |
| hl7.fhir.uv.cg-incubator | R6 | ValueSet-moleculardefinition-organism.json | Molecular Definition Organism | informative | 0 | cg | 2026-03 | uv | hl7 | 1 | |
| silfhirprofileig | R5 | ValueSet-procedure-outcome.json | SGHI Procedure outcome value set | draft | 2026-03 | internal | 1 | ||||
| ng.gov.nphcda.immunization | R4 | ValueSet-ng-facility-identifier-vs.json | NG-Imm Clinical Status VS | active | 2026-04 | internal | |||||
| ng.gov.nphcda.immunization | R4 | ValueSet-nigeria-clinical-status.json | NG-Imm Clinical Status VS | active | 2026-04 | internal | |||||
| ng.gov.nphcda.immunization | R4 | ValueSet-nigeria-pregnancy-status.json | NG-Imm Clinical Status VS | active | 2026-04 | internal | 3 | ||||
| org.dhin-hie.sandbox | R4 | ValueSet-ng-facility-identifier-vs.json | NG Clinical Status VS | active | 2026-02 | internal | |||||
| org.dhin-hie.sandbox | R4 | ValueSet-nigeria-clinical-status.json | NG Clinical Status VS | active | 2026-02 | internal | |||||
| org.dhin-hie.sandbox | R4 | ValueSet-nigeria-pregnancy-status.json | NG Clinical Status VS | active | 2026-02 | internal | 1 | ||||
| hl7.fhir.uv.cardx-cied | R5 | ValueSet-cied-connectivity-state-vs.json | CIED Connectivity Status Value Set | trial-use | 2 | cic | 2026-04 | uv | hl7 | fhir | 1 |
| org.dhin-hie.sandbox | R4 | ValueSet-nigeria-location-owner.json | NG Location Owner | active | 2026-02 | internal | 1 | ||||
| ng.gov.nphcda.immunization | R4 | ValueSet-nigeria-location-owner.json | NG-Imm Location Owner | active | 2026-04 | internal | 1 | ||||
| ch.fhir.ig.ch-crl | R4 | ValueSet-nkrs-irssstaging.json | NKRS - IRSS Staging | active | 2022-02 | ch | hl7 | internal | 1 | ||
| ca.infoway.io.psca | R4 | valueset-immunizationrouteofadministrationcode.json | Immunization Route Of Administration Code | draft | 1900-01 | ca | national | sct | 1 | ||
| hl7.terminology | R5 | ValueSet-v3-RouteOfAdministration.json | RouteOfAdministration | active | 2014-03 | uv | hl7 | tho | 3 | ||
| hl7.fhir.us.breastcancer | R3 | ValueSet-oncology-LymphNodeInvolvementVS.json | BC LymphNodeInvolvementVS ValueSet | draft | 2018-08 | us | hl7 | sct | 2 | ||
| us.cdc.phinvads | R4 | ValueSet-2.16.840.1.114222.4.11.998.json | HIV Status | active | 2008-01 | us | sct tho oid | ||||
| hl7.fhir.uv.extensions | R5 | ValueSet-patient-unknownIdentity.json | Patient's/person's identity is known/unknown | draft | pa | 2026-04 | uv | hl7 | fhir | ||
| hl7.terminology | R5 | ValueSet-v3-ParticipationReceiver.json | ParticipationReceiver | active | 2014-03 | uv | hl7 | tho | |||
| hl7.terminology | R5 | ValueSet-v3-ParticipationResponsibleParty.json | ParticipationResponsibleParty | active | 2014-03 | uv | hl7 | tho |